Drugs / Wangbi granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05540938 | May 2023 → Dec 2025 overdue | rheumatoid arthritis | China-Japan Friendship Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wangbi granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05540938 ↗ |
| Known as | Wangbi granule | “As a traditional Chinese medicine preparation, Wangbi granule showed a synergistic role with methotrexate in the treatment of RA patients with "kidney deficiency and dampness"...” PMID 36855169 ↗ Feb 2023 |
| Modality | Traditional medicine (herbal / TCM) | “As a traditional Chinese medicine preparation, Wangbi granule showed a synergistic role with methotrexate” PMID 36855169 ↗ Feb 2023 |